Triple-negative breast cancer: biology, pathology, and treatment

Abstract

Triple negative breast cancer (TNBC) is a subtype of breast tumor which comprises 24% of newly diagnosed tumors that lacks hormone receptor expression and HER2 gene amplification. This study illustrated the pathological features of triple negative breast cancer with special reference to the landmark research that molecularly characterize this subtype of breast cancer. Additionally, this article discusses functional problems with arisen in clinical routine as a result of advent genetic expression breast cancer profiling and it's novel prognostic and predictive effects on triple-negative breast cancer pathology. Additionally, histopathological features of triple-negative neoplasms are discussed, emphasizing the critical nature of histologic detection in specific cancer subtypes with a significant effect on clinical results. Notably, emphasis is placed on the emerging clinical frontier represented by immunotherapy, with special emphasis on the implementation of immune checkpoint inhibitors in TNBC therapy and their effect on potential treatments.

Authors and Affiliations

Ali Miri; Ebrahim Kiani; Sajad Habibi; Mostafa Khafaei

Keywords

Related Articles

Stem cell therapy as a promising approach in the treatment of neurodegenerative disorders

Neurodegenerative diseases in humans such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, and Huntington's disease are associated with the loss of neurons or glial cells in the central nervous sy...

Genetic and epigenetic collaboration in Parkinson’s disease

Parkinson's disease (PD) is a common neurodegenerative syndrome directly related to age development. This pathologic condition presents in many types of forms. Some efforts applied to understand PD development include re...

Potential therapeutic effects of herbal drug resveratrol against cancer

Cancer is a major global problem that faces many therapeutic challenges. Drug resistance can be an important problem in cancer treatment with chemotherapy. The use of plant-based compounds that have anti-cancer propertie...

Triple-negative breast cancer: biology, pathology, and treatment

Triple negative breast cancer (TNBC) is a subtype of breast tumor which comprises 24% of newly diagnosed tumors that lacks hormone receptor expression and HER2 gene amplification. This study illustrated the pathological...

Correlation of a well-known genetic variation in one carbon metabolism pathway with breast cancer susceptibility in Iranian population

The one carbon metabolism pathway is an important cycle in the cellular reactions. One of a key gene in the mentioned pathway is methylenetetrahydrofolate reductase. This gene contains numerous variations that the rs1801...

Download PDF file
  • EP ID EP714128
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Ali Miri; Ebrahim Kiani; Sajad Habibi; Mostafa Khafaei (2021). Triple-negative breast cancer: biology, pathology, and treatment. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation, 1(2), -. https://europub.co.uk/articles/-A-714128